Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ryoko Serizawa"'
Autor:
Nobuyoshi Imai, Tetsuo Nakata, Jiahong Wang, Miyuki Kobara, Tamotsu Takahashi, Takuya Mitani, Ryoko Serizawa, Hiroe Toba
Publikováno v:
Clinical and Experimental Pharmacology and Physiology. 37:1064-1070
1. The aim of the present study was to investigate whether or not pitavastatin ameliorates diabetic nephropathy and if inhibition of the rennin-angiotensin-aldosterone system (RAAS) is associated with any renoprotective effects. Pitavastatin (10mg/ k
Autor:
Hiroe, Toba, Takuya, Mitani, Tamotsu, Takahashi, Nobuyoshi, Imai, Ryoko, Serizawa, Jiahong, Wang, Miyuki, Kobara, Tetsuo, Nakata
Publikováno v:
Clinical and experimental pharmacologyphysiology. 37(11)
1. The aim of the present study was to investigate whether or not pitavastatin ameliorates diabetic nephropathy and if inhibition of the rennin-angiotensin-aldosterone system (RAAS) is associated with any renoprotective effects. Pitavastatin (10mg/ k
Autor:
Masafumi Murakami, Miyuki Kobara, Masateru Taira, Ryoko Serizawa, Hiroe Toba, Shoko Murata, Ikumi Iga, Tetsuo Nakata
Publikováno v:
European journal of pharmacology. 589(1-3)
Aldosterone itself has been reported to participate in mediating renal injury, and it was confirmed that the aldosterone synthase CYP11B2 gene, protein, and aldosterone production are locally present in the kidney. To test the hypothesis that a miner